170 related articles for article (PubMed ID: 37450706)
41. Association of Adjuvant Radiotherapy With Survival After Margin-negative Resection of Pancreatic Ductal Adenocarcinoma: A Propensity-matched National Cancer Database (NCDB) Analysis.
Kamarajah SK; Sonnenday CJ; Cho CS; Frankel TL; Bednar F; Lawrence TS; Nathan H
Ann Surg; 2021 Mar; 273(3):587-594. PubMed ID: 30817352
[TBL] [Abstract][Full Text] [Related]
42. Prognostic impact of resection margin status on survival after neoadjuvant treatment for pancreatic cancer: systematic review and meta-analysis.
Leonhardt CS; Hank T; Pils D; Gustorff C; Sahora K; Schindl M; Verbeke CS; Strobel O; Klaiber U
Int J Surg; 2024 Jan; 110(1):453-463. PubMed ID: 38315795
[TBL] [Abstract][Full Text] [Related]
43. Prognostic Impact of Preoperative Osteosarcopenia for Patients with Pancreatic Ductal Adenocarcinoma After Curative Resection.
Abe T; Nakata K; Nakamura S; Ideno N; Ikenaga N; Fujita N; Ishigami K; Nishihara K; Nakamura M
Ann Surg Oncol; 2023 Oct; 30(11):6673-6679. PubMed ID: 37466870
[TBL] [Abstract][Full Text] [Related]
44. A novel online calculator to predict early recurrence and long-term survival of patients with resectable pancreatic ductal adenocarcinoma after pancreaticoduodenectomy: A multicenter study.
Zhang XP; Gao YX; Xu S; Zhao GD; Hu MG; Tan XL; Zhao ZM; Liu R
Int J Surg; 2022 Oct; 106():106891. PubMed ID: 36165934
[TBL] [Abstract][Full Text] [Related]
45. Robotic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: Analysis of surgical outcomes and long-term prognosis in a high-volume center.
Zhang XP; Xu S; Zhao ZM; Liu Q; Zhao GD; Hu MG; Tan XL; Liu R
Hepatobiliary Pancreat Dis Int; 2023 Apr; 22(2):140-146. PubMed ID: 36171169
[TBL] [Abstract][Full Text] [Related]
46. Predictors for Survival in an International Cohort of Patients Undergoing Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma.
Korrel M; Lof S; van Hilst J; Alseidi A; Boggi U; Busch OR; van Dieren S; Edwin B; Fuks D; Hackert T; Keck T; Khatkov I; Malleo G; Poves I; Sahakyan MA; Bassi C; Abu Hilal M; Besselink MG;
Ann Surg Oncol; 2021 Feb; 28(2):1079-1087. PubMed ID: 32583198
[TBL] [Abstract][Full Text] [Related]
47. Proposed preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after surgical resection: A multi-center retrospective study.
Matsumoto I; Murakami Y; Shinzeki M; Asari S; Goto T; Tani M; Motoi F; Uemura K; Sho M; Satoi S; Honda G; Yamaue H; Unno M; Akahori T; Kwon AH; Kurata M; Ajiki T; Fukumoto T; Ku Y
Pancreatology; 2015; 15(6):674-80. PubMed ID: 26467797
[TBL] [Abstract][Full Text] [Related]
48. Prediction of residual tumor and overall survival after first-line surgery in patients with pancreatic ductal adenocarcinoma using preoperative magnetic resonance imaging findings.
Bae JS; Kim JH; Kang HJ; Han JK
Acta Radiol; 2022 Apr; 63(4):435-446. PubMed ID: 33682455
[TBL] [Abstract][Full Text] [Related]
49. The impact of margin status determined by the one-millimeter rule on tumor recurrence and survival following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Nitta T; Nakamura T; Mitsuhashi T; Asano T; Okamura K; Tsuchikawa T; Tamoto E; Murakami S; Noji T; Kurashima Y; Ebihara Y; Nakanishi Y; Shichinohe T; Hirano S
Surg Today; 2017 Apr; 47(4):490-497. PubMed ID: 27677294
[TBL] [Abstract][Full Text] [Related]
50. Prognostic effect of CD73 in pancreatic ductal adenocarcinoma for disease-free survival after radical surgery.
Qin D; Wei R; Huang K; Wang R; Ding H; Yao Z; Xi P; Li S
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7805-7817. PubMed ID: 37032378
[TBL] [Abstract][Full Text] [Related]
51. A nomogram based on preoperative inflammatory markers predicting the overall survival of pancreatic ductal adenocarcinoma.
Xu J; Shi KQ; Chen BC; Huang ZP; Lu FY; Zhou MT
J Gastroenterol Hepatol; 2017 Jul; 32(7):1394-1402. PubMed ID: 27973703
[TBL] [Abstract][Full Text] [Related]
52. Cachexia index as a prognostic predictor after resection of pancreatic ductal adenocarcinoma.
Shimagaki T; Sugimachi K; Mano Y; Onishi E; Iguchi T; Nakashima Y; Sugiyama M; Yamamoto M; Morita M; Toh Y
Ann Gastroenterol Surg; 2023 Nov; 7(6):977-986. PubMed ID: 37927935
[TBL] [Abstract][Full Text] [Related]
53. Elevated preoperative plasma D-dimer level was an independent prognostic factor for patients with PDAC after curative resection: a retrospective analysis.
Zhifei L; Yuexiang L; Shaofei C; Shuo L; Hongwei W; Chuntao G
Jpn J Clin Oncol; 2023 Nov; 53(11):1058-1067. PubMed ID: 37539583
[TBL] [Abstract][Full Text] [Related]
54. The role of coeliac axis resection in resected ductal adenocarcinoma of the distal pancreas: A result of tumour topography or a prognostic factor?
Liu B; Wu J; Li C; Li Y; Qiu H; Lv A; Liu Q; Liu D; Wang Z; Hao C
Pancreatology; 2022 Jan; 22(1):112-122. PubMed ID: 34764022
[TBL] [Abstract][Full Text] [Related]
55. Impact of resection margin status on recurrence and survival in pancreatic cancer surgery.
Tummers WS; Groen JV; Sibinga Mulder BG; Farina-Sarasqueta A; Morreau J; Putter H; van de Velde CJ; Vahrmeijer AL; Bonsing BA; Mieog JS; Swijnenburg RJ
Br J Surg; 2019 Jul; 106(8):1055-1065. PubMed ID: 30883699
[TBL] [Abstract][Full Text] [Related]
56. Preoperative predictors for early and very early disease recurrence in patients undergoing resection of pancreatic ductal adenocarcinoma.
Daamen LA; Dorland G; Brada LJH; Groot VP; van Oosten AF; Besselink MG; Bosscha K; Bonsing BA; Busch OR; Cirkel GA; van Dam RM; Festen S; Groot Koerkamp B; Haj Mohammad N; van der Harst E; de Hingh IHJT; Intven MPW; Kazemier G; Los M; de Meijer VE; Nieuwenhuijs VB; Roos D; Schreinemakers JMJ; Stommel MWJ; Verdonk RC; Verkooijen HM; Molenaar IQ; van Santvoort HC;
HPB (Oxford); 2022 Apr; 24(4):535-546. PubMed ID: 34642090
[TBL] [Abstract][Full Text] [Related]
57. Pancreatic Ductal Adenocarcinoma: Rim Enhancement at MR Imaging Predicts Prognosis after Curative Resection.
Lee S; Kim SH; Park HK; Jang KT; Hwang JA; Kim S
Radiology; 2018 Aug; 288(2):456-466. PubMed ID: 29664340
[TBL] [Abstract][Full Text] [Related]
58. The impact of resection margin distance on survival and recurrence in pancreatic ductal adenocarcinoma in a retrospective cohort analysis.
Obonyo D; Uslar VN; Münding J; Weyhe D; Tannapfel A
PLoS One; 2023; 18(2):e0281921. PubMed ID: 36800357
[TBL] [Abstract][Full Text] [Related]
59. Identification of intratumoral fluid-containing area by magnetic resonance imaging to predict prognosis in patients with pancreatic ductal adenocarcinoma after curative resection.
Kim H; Kim DH; Song IH; Youn SY; Kim B; Oh SN; Choi JI; Rha SE
Eur Radiol; 2022 Apr; 32(4):2518-2528. PubMed ID: 34671833
[TBL] [Abstract][Full Text] [Related]
60. Survival After Minimally Invasive vs Open Surgery for Pancreatic Adenocarcinoma.
Topal H; Aerts R; Laenen A; Collignon A; Jaekers J; Geers J; Topal B
JAMA Netw Open; 2022 Dec; 5(12):e2248147. PubMed ID: 36547979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
